Oral Alkylating Agents for Breast Cancer Therapy
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 58 (3), 1-9
- https://doi.org/10.2165/00003495-199958003-00001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Improving Fluorouracil Chemotherapy with Novel Orally Administered FluoropyrimidinesDrugs, 1999
- The charing cross hospital experience with temozolomide in patients with gliomasEuropean Journal of Cancer, 1996
- Evolving concepts in the systemic adjuvant treatment of breast cancer.1992
- Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)British Journal of Cancer, 1992
- Combination of Idarubicin and Cyclophosphamide Administered Orally in Untreated Postmenopausal Breast Cancer PatientsOncology, 1991
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.Journal of Clinical Oncology, 1990
- The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patientsAnnals of Oncology, 1990
- Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.Journal of Clinical Oncology, 1989
- Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.Journal of Clinical Oncology, 1986
- DNA DAMAGE AND REPAIR IN MOUSE LEUKEMIA-L1210 CELLS TREATED WITH NITROGEN-MUSTARD, 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA, AND OTHER NITROSOUREAS1977